Editor in Chief PharmacoEconomics. Past President ISPOR NZ Chapter, ex pharmacist, run and play the piano. UK expat in New Zealand. All views are my own
Joined January 2010
- Tweets 9,381
- Following 1,325
- Followers 2,334
- Likes 2,081
Photos and videos
12 Feb 2025
1
80
13 Sep 2024
PharmacoEconomics has a Call For Papers for a themed issue on individual level models link.springer.com/collection…
1
109
Chris Carswell retweeted
13 Sep 2024
A much needed reporting checklist for discrete choice experiments link.springer.com/article/10…
2
5
223
13 Sep 2024
Seems to me the QALY is so entrenched in many countries it would take a huge effort to move away from it
1
191
Chris Carswell retweeted
19 Jan 2024
Second, this solo editorial in Pharmacoeconomics, called "Making Models Fit for Purpose: the Importance of Ensuring Stakeholder Involvement". Also available free right here! rdcu.be/dwnP1
3
4
690
Chris Carswell retweeted
8 Dec 2023
My 'Framework for the Fair Pricing of Medicines' has just been published as a Leading Article by Pharmacoeconomics. This framework proposes a number of advancements to existing approaches for specifying a 'cost-effectiveness threshold' for new medicines. link.springer.com/article/10…
1
8
24
2,293
Chris Carswell retweeted
5 Sep 2023
Including carer outcomes in economic evaluation is important & can reveal unrecognised challenges in HTA decisions.
One of these is where patient & carer QALYs point in different directions - work led by @davidjohnmott and colleagues @OHENews @HEU_UoB
link.springer.com/article/10…
18
37
4,521
Chris Carswell retweeted
6 Aug 2023
1/3 "Using Age-Specific Values for Pediatric HRQoL in CEA: Is There a Problem to Be Solved? If So, How?" available here👉 tinyurl.com/45xn56sk
Really pleased this paper is out - hope it serves to progress the debate! @stolk_elly @MJSculpher @rich_norman @QUOKKA_Research
1
9
22
1,359
Chris Carswell retweeted
2 May 2023
Thread update on the QUOKKA project led by the brilliant @nancydevlin1 - huge output from this multi-university project on measuring and valuing child QoL
2 May 2023
1/10 Time flies! @QUOKKA_Research is now in its 3rd and final year. Here's a thread with a quick overview of where we're at and what we'll be doing this year!
2
7
624
22 Mar 2023
Terrible grammar is a key sign!
Academic publishing scams are getting very good, having had a paper published yesterday this came through soon after. If it wasn't for the terrible grammar I would have clicked on the link. Be careful out there! I was so pleased I'd been nominated!
1
276
Chris Carswell retweeted
22 Mar 2023
Congratulations @dinaabushanab10 on this massive work on projecting the health and economic burden of CVD among people with type 2 diabetes @claremarquina @JedidiahMorton @PECjournal link.springer.com/article/10…
2
4
8
549
Chris Carswell retweeted
2 Mar 2023
In preparation for my new class @HarrisPolicy, I asked ChatGPT:
“How to conduct cost-effectiveness analysis (CEA)?”
ChatGPT provides a very solid high-level summary, and I don’t think I can do a better job.
Thoughts? @PeterNeumann11 @Basucally @AnkurFactorial @WrightCensored
2
4
31
3,325
Chris Carswell retweeted
2 Mar 2023
At @ipha's conference. The Minister just mentioned Ireland's €45,000/QALY threshold and that there is an existing pathway for orphan drugs to exceed it. Interesting confirmation of the threshold and that it doesn't always apply.
1
1
9
947
Chris Carswell retweeted
24 Feb 2023
@BCNHealth publishes a study reviewing economic evaluations and burden of disease studies of endometriosis
#health #review #economic #evaluation #burden #disease #endometriosis #costs #indirect #productivity #losses
bit.ly/3EBmAZT
3
2
114
Chris Carswell retweeted
13 Feb 2023
Antimicrobial resistance or #AMR, as known in short, is a global health crisis.
Find out how we're applying a new 'Netflix' style payment model to boost the antimicrobial pipeline, which has already assessed 2 new antimicrobial drugs⬇️
link.springer.com/article/10…
1
10
12
11,083
Long shot but are there any health economist out there would would review a journal paper for me? My last PhD by publication paper has been stuck in one journal for 5 months with no reviewers, I think it is now down to me to find one!
3
11
11
4,262